Tenax Therapeutics Inc. (TENX)
NASDAQ · Healthcare
Tenax Therapeutics Inc. EPS 2011–2025
Tenax Therapeutics Inc. annual/quarterly eps history and growth rate from 2011 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Tenax Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.35, a 25.00% increase year-over-year.
- Tenax Therapeutics Inc. annual eps for 2025 was $1.34, a 16.52% increase from 2024.
- Tenax Therapeutics Inc. annual eps for 2024 was $1.15, a 130.00% increase from 2015.
- Tenax Therapeutics Inc. annual eps for 2015 was $0.50, a 81.55% decrease from 2014.
- Tenax Therapeutics Inc. annual eps for 2014 was $2.71.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Tenax Therapeutics Inc. EPS — FAQ
Tenax Therapeutics Inc. (TENX) eps over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Tenax Therapeutics Inc.'s eps?
Tenax Therapeutics Inc. (TENX) reported eps of $-1.34 for fiscal 2025.
Where can I see TENX's eps history?
The chart and table above show Tenax Therapeutics Inc.'s eps by year and by quarter, including the growth rate.